Sector: Pharmaceuticals & Biotechnology - Healthcare
BSE Code: 506128
NSE Symbol: PARNAXLAB
ISIN: INE383L01019
📊 Parnax Lab Q3 2025 Results: Revenue & Margins at a Glance • Standalone Q3 2025 revenue: ₹270.82 lakhs, with net profit of ₹70.91 lakhs. • Standalone 9-month revenue: ₹637.68 lakhs, net profit: ₹143.74 lakhs. • Consolidated Q3 2025 revenue: ₹6,294.15 lakhs, net profit: ₹271.47 lakhs. • Consolida…
📊 Parnax Lab Board Meeting Set for Feb 13, 2026 to Review Q3 & 9M FY25 Results - Board meeting scheduled for February 13, 2026 - Will review standalone and consolidated un-audited IND-AS financial results for Q3 and nine months ended December 31, 2025 - Trading window for equity shares closed sin…
Parnax Lab Compliance Update: Key Quarter-End Details 📋 - Parnax Lab submitted a compliance certificate for the quarter ended December 31, 2025. - No dematerialization requests were received during this quarter. - MUFG Intime India Private Limited (Registrar & Transfer Agent) confirmed all securi…
📊 Parnax Lab Q2 FY2026 Results: Revenue at ₹62.6 Cr, PAT ₹3.62 Cr - Parnax Lab's Q2 FY2026 standalone revenue: ₹62.60 Cr (operations), ₹63.23 Cr (total) - Standalone Q2 profit: ₹5.20 Cr (PBT), ₹3.62 Cr (PAT) - Consolidated Q2 revenue matches standalone at ₹62.60 Cr (operations) - Consolidated Q2 …
📅 Parnax Lab Board Meeting: Q2 & Half-Year Results on Nov 14, 2025 - Board meeting scheduled for November 14, 2025, at Parnax Lab's registered office. - Agenda includes approval of Standalone and Consolidated Un-audited IND-AS Compliant Financial Results for Q2 and half year ended September 30, 2…
Parnax Lab Appoints New Secretarial Auditor for Next 5 Years 📋 - Shareholders approved M/s HSPN & Associates LLP as Secretarial Auditor for FY 2025-26 to FY 2029-30. - Decision made at the 43rd Annual General Meeting on September 29, 2025. - Replaces previous auditor whose tenure ended March 31, …
Parnax Lab Q1 FY26 Results: Standalone & Consolidated Performance 📊 - Standalone Revenue from Operations for Q1 FY26: ₹196.75 lakhs - Consolidated Revenue from Operations for Q1 FY26: ₹5337.55 lakhs - Standalone Profit Before Tax for Q1 FY26: ₹31.39 lakhs - Consolidated Profit Before Tax for Q1 F…
Parnax Lab Q1 Results & AGM Date Decision on Aug 13 📅 - Board meeting on August 13, 2025, to approve Q1 (June 30, 2025) financial results. - Decision on AGM date for FY ending March 31, 2025, also on the agenda. - Trading window closed from July 1, 2025, until 48 hours post-results announcement.